USP4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.077800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.536400E-02
Normal-vs-Stage2
1.150960E-01
Normal-vs-Stage3
5.740300E-02
Normal-vs-Stage4
8.892400E-01
Stage1-vs-Stage2
1.578250E-01
Stage1-vs-Stage3
2.156400E-01
Stage1-vs-Stage4
1.095870E-02
Stage2-vs-Stage3
2.147700E-02
Stage2-vs-Stage4
1.103380E-01
Stage3-vs-Stage4
7.197100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.630300E-02
Normal-vs-AfricanAmerican
2.388600E-01
Normal-vs-Asian
9.564500E-02
Caucasian-vs-AfricanAmerican
8.834200E-01
Caucasian-vs-Asian
3.763200E-01
AfricanAmerican-vs-Asian
6.693600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.391570E-01
Normal-vs-Female
5.186500E-02
Male-vs-Female
6.229000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.718970E-01
Normal-vs-Age(41-60Yrs)
2.148600E-01
Normal-vs-Age(61-80Yrs)
6.275800E-02
Normal-vs-Age(81-100Yrs)
1.712450E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.294400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.637800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.088000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.237670E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.032600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.484400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.138100E-02
Normal-vs-Daily Drinker
1.921420E-01
Normal-vs-Weekly Drinker
1.072240E-01
Normal-vs-Occasional Drinker
3.788600E-01
Normal-vs-Social Drinker
1.260370E-01
Non Drinker-vs-Daily Drinker
6.929600E-01
Non Drinker-vs-Weekly Drinker
6.520200E-01
Non Drinker-vs-Occasional Drinker
5.974400E-02
Non Drinker-vs-Social Drinker
3.915200E-01
Daily Drinker-vs-Weekly Drinker
9.672400E-01
Daily Drinker-vs-Occasional Drinker
2.194400E-01
Daily Drinker-vs-Social Drinker
7.193200E-01
Weekly Drinker-vs-Occasional Drinker
1.981780E-01
Weekly Drinker-vs-Social Drinker
7.034800E-01
Occasional Drinker-vs-Social Drinker
3.188400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.482600E-01
Normal-vs-Grade 2
5.417400E-01
Normal-vs-Grade 3
5.106400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.380300E-03
Grade 1-vs-Grade 3
1.661350E-03
Grade 1-vs-Grade 4
3.482600E-01
Grade 2-vs-Grade 3
3.655400E-01
Grade 2-vs-Grade 4
5.417400E-01
Grade 3-vs-Grade 4
5.106400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.673650E-01
Normal-vs-NonDiabetic
5.209700E-02
Diabetic-vs-NonDiabetic
9.066000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.708000E-01
Normal-vs-NoPancreatitis
6.323900E-02
Pancreatitis-vs-NoPancreatitis
2.491800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.032760E-01
Normal-vs-N1
9.951900E-02
N0-vs-N1
6.157400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.949200E-01
Normal-vs-TP53-NonMutant
6.188500E-02
TP53-Mutant-vs-TP53-NonMutant
6.823800E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
